日本10月基礎貨幣年率 -13.6%，前值-15.20%。

Hong Kong-listed innovative drug stocks rallied in afternoon trade: WuXi Biologics (02269.HK) and Wuxi AppTec (02359.HK) gained over 9%, BeiGene (06160.HK) rose more than 7%; CSPC Pharma (01093.HK) and Akeso (09926.HK) also advanced.

Nov. 3, 2026, Guangzhou — The 2026 Guangdong–Hong Kong–Macao Greater Bay Area global investment conference, jointly hosted by the Guangdong provincial government and the Hong Kong and Macao SAR governments, attracted 413 companies and trade-association delegates from 17 countries and regions. The conference has cumulatively signed more than 5,700 projects worth over CNY9 trillion; projects from the first four conferences have an overall commencement rate above 90%. Deals have steered strategic emerging industries — biopharmaceuticals, green petrochemicals, new energy, advanced materials, electronic information and automotive — toward higher value-added segments of the value chain.